The vaping cessation pill, varenicline, has emerged as a revolutionary tool for those struggling to quit vaping, particularly among teenagers and young adults.Recent clinical trials show that participants aged 16 to 25 who utilized this FDA-approved smoking cessation pill were over three times more successful in ceasing their vaping habits compared to their peers using only behavioral therapy.